JNJ - Johnson & Johnson

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2019
12/30/2018
12/30/2017
12/30/2016
Total Revenue
82,059,000
-
81,581,000
76,450,000
71,890,000
Cost of Revenue
27,556,000
-
27,091,000
25,354,000
21,685,000
Gross Profit
54,503,000
-
54,490,000
51,096,000
50,205,000
Operating Expenses
Research Development
12,245,000
-
11,901,000
10,962,000
9,124,000
Selling General and Administrative
22,178,000
-
22,540,000
21,420,000
19,945,000
Total Operating Expenses
34,423,000
-
34,441,000
32,382,000
29,069,000
Operating Income or Loss
20,080,000
-
20,049,000
18,714,000
21,136,000
Interest Expense
318,000
-
1,005,000
934,000
726,000
Total Other Income/Expenses Net
-2,791,000
-
-1,656,000
-492,000
-975,000
Income Before Tax
17,328,000
-
17,999,000
17,673,000
19,803,000
Income Tax Expense
2,209,000
-
2,702,000
16,373,000
3,263,000
Income from Continuing Operations
15,119,000
-
15,297,000
1,300,000
16,540,000
Net Income
15,119,000
-
15,297,000
1,300,000
16,540,000
Net Income available to common shareholders
15,119,000
-
15,297,000
1,300,000
16,540,000
Reported EPS
Basic
-
5.72
5.75
0.48
6.08
Diluted
-
5.63
5.61
0.47
5.93
Weighted average shares outstanding
Basic
-
2,645,100
2,662,324
2,682,525
2,706,511
Diluted
-
2,684,300
2,728,700
2,745,300
2,788,900
EBITDA
-
-
25,933,000
24,249,000
24,283,000